Nuvation Bioの空売り状況は、投資家がNuvation Bioの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Nuvation Bio (NYSE:NUVB) 株価情報, 空売り情報

NUVATION BIO INC

Nuvation Bio

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Nuvation Bio Inc

B of A Securities analyst Tazeen Ahmad maintains Sutro Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>) with a Underperform and lowers the price target from $1 to $0.8.

News

Price Target

Analyst Ratings

STRO

B of A Securities Maintains Underperform on Sutro Biopharma, Lowers Price Target to $0.8

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon, known for <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44294343/jamie-dimons-crypto-change-of-heart-trump-once-claimed-shift-but-jpmorgan-ceo-still-a-skeptic-when-it-comes-to-bitcoin">his repeated criticisms</a> of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), acknowledged at the bank's investor day this week that the firm will now allow clients to buy the cryptocurrency, though it will not offer custody services.
What Happened: Dimon's remarks mark a shift in tone for the leader of the largest U.S. bank, <a href="https://www.theblock.co/post/354883/jamie-dimon-says-jpmorgan-will-allow-clients-to-buy-bitcoin-but-firm-will-not-custody-it?utm_source=twitter&amp;utm_medium=social">according</a> to The Block.
Despite referring to Bitcoin as a "<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42940832/jamie-dimon-says-hes-not-against-blockchains-but-trades-guns-on-bitcoin-again-it-has-no-intrinsic-value-i-just-dont-feel-great-about">Ponzi scheme</a>" as recently as January and maintaining he sees "no value" in it, the firm is adapting to rising institutional and retail demand for digital assets.
The CEO also remained skeptical about blockchain's long-term impact. 
"We've been talking about blockchain for 12 years, not much has happened, it ain't like AI," he said at a separate event in September 2024.
Although Dimon continues to distance himself from Bitcoin philosophically, his bank has become increasingly engaged with the broader blockchain sector. 
Last year, he acknowledged JPMorgan as <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44033154/jamie-dimon-was-a-believer-in-smart-contract-cryptos-long-before-jpmorgan-started-piling-on-ethereum-etfs-heres-what-he-said">a significant user</a> of blockchain technology, highlighting the firm&#8217;s involvement in various enterprise initiatives.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45498737/altcoin-rotation-is-coming-expert-says-will-eth-xrp-dogecoin-benefit">Altcoin Rotation Is Coming, Expert Says: Will ETH, XRP, Dogecoin Benefit?</a>
Why It Matters: The firm's evolving stance comes amid a broader policy shift in Washington.
The Trump administration has taken a more favorable view of digital assets, prompting more engagement from traditional financial institutions. 
Earlier this year, Federal Reserve Chair Jerome Powell said U.S. banks can serve crypto clients, provided they adequately manage the associated risks.
Still, regulatory concerns remain. 
In January, TD Cowen noted that banks are likely to maintain limited exposure to crypto due to ongoing worries around money laundering compliance and risk management frameworks.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45496435/strategy-adds-765-million-in-bitcoin-faces-lawsuit-over-btc-holdings">Strategy Adds $765 Million In Bitcoin, Faces Lawsuit Over BTC Holdings</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Jamie Dimon Opens JPMorgan To Bitcoin Access Despite Longstanding Criticism

B of A Securities analyst Tazeen Ahmad maintains Denali Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) with a Buy and lowers the price target from $28 to $27.

DNLI

B of A Securities Maintains Buy on Denali Therapeutics, Lowers Price Target to $27

B of A Securities analyst Sara Senatore maintains Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) with a Buy and raises the price target from $112 to $121.

CAVA

B of A Securities Maintains Buy on Cava Group, Raises Price Target to $121

Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) continues to head lower Monday. This follows Friday's loss of more than 4.5% after <a href="https://www.benzinga.com/top-stories/25/05/45381191/first-solar-eyes-best-2-day-rally-since-2013-after-gop-tax-plan-spares-key-clean-energy-credits">recent gains</a>. There is a good chance the move lower will continue.
A recent move higher was probably due to a short squeeze. Stocks can drop significantly when a short squeeze ends. This is why our trading team has made Sunrun our Stock of the Day.
People who sell short anticipate a decline in the price of a stock.
They borrow shares from someone else and sell them. They hope that after the stock declines, they will buy the shares back and return them. Their profit will be the price they sold short for minus the price they bought the shares back at.
If a stock rises above the price the short seller sold the shares for, they start to lose money. And if the price keeps rising, their losses grow. Sometimes, some of the short sellers start to panic as the stock continues to rally.
They enter the market as buyers and this forces the price even higher.
Read Also: <a href="https://www.benzinga.com/government/25/05/45499183/how-tariff-uncertainty-is-driving-a-us-talent-exodus">How Tariff Uncertainty Is Driving A US Talent Exodus</a>
If the price gets high enough, some of the people who loaned their shares to the short sellers will decide they want to sell them. This forces the short seller to buy the shares back regardless of the price, so they can return them.
At this point, the stock can go parabolic. As you can see on the chart, this is what happened with Sunrun last week.
When a short squeeze ends and the panic is over, the stock typically makes a rapid and large move lower. They can even drop back to the levels they were trading at when the squeeze started.
It isn't a coincidence that Sunrun reversed off the $13.35 level. This level had been support and prices that were support can turn into resistance.
Some who bought shares in October saw an opportunity to finally exit their positions at breakeven when the stock returned to this price last week. The large amounts of sell orders placed by these remorseful buyers created resistance at the price that was support.
As this short squeeze unwinds, there is a good chance the stock continues to head lower.
Read Next: • <a href="https://www.benzinga.com/25/05/45492889/americas-credit-strength-just-got-cut-again-should-you-panic">America&#8217;s Credit Strength Just Got Cut Again: Should You Panic?</a>
Photo: Shutterstock

Technicals

Options

Trading Ideas

Stock Of The Day: Is The Sunrun Short Squeeze Over?

WIIM

AutoZone shares are trading higher after Wells Fargo raised its price target from $3,850 to $4,200 while maintaining an Overweight rating.

ENPH

FSLR

Shares of solar stocks are trading lower amid political risk to clean-energy incentives following reports detailing GOP plans to cut clean-energy credits.

Piper Sandler analyst Jason Bednar upgrades Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) from Neutral to Overweight and raises the price target from $78 to $87.

Upgrades

SOLV

Piper Sandler Upgrades Solventum to Overweight, Raises Price Target to $87

<a href="https://www.youtube.com/watch?v=KeGLM7JPPYo">https://www.youtube.com/watch?v=KeGLM7JPPYo</a>

Politics

Economics

Federal Reserve

General

Fed's Kashkari Says Very Bullish There Will Be Lots Of Jobs In Future U.S. Economy

HC Wainwright &amp; Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ARMP#AMEX">ARMP</a>) with a Buy and raises the price target from $7 to $9.

ARMP

HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $9

One of the benefits&nbsp;<a href="https://substack.com/redirect/1b7f3cf6-9b8c-48b8-9e8c-657e8bb35809?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">of aging</a>&nbsp;as an investor is that you accumulate invaluable experience and perspective by living through a lot of very bad economic and financial market events.
These include events when, in the moment, it felt like things had permanently taken a turn for the worse. But time after time, you're reminded that you can't keep the U.S. economy and stock market down for very long.
I like to reflect on those events and recall the unpleasant memories because it helps me better process current and future periods of turmoil and crisis. And the more I reflect, the more I feel like I understand why we keep bouncing back.
<h2 class="wp-block-heading">From the Asian Financial Crisis to the COVID-19 Pandemic </h2>
In the late 1990s, I was just another immature high school kid without many cares in the world. I didn't really keep up with current events. But I remember the Asian Financial Crisis because it was one of the topics in prayers my dad would give at his church in Kentucky. I'll never forget hearing "IMF" come up in those Korean prayers because it was so unusual.
Among other things, the Korean won collapsed by more than half against the U.S. dollar over a very short period at the time. This was a particularly big problem for immigrants closely tied to family back in Korea. I didn't quite understand it at the time, but I remember the mood being disturbingly gloomy for a while.
<figure class="wp-block-image"><a href="https://substack.com/redirect/8c96a367-2e63-438d-a2f7-10c8651a8053?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NbINJfv5qQh_mHfNAY3Ren2hmfavqULpETqyrT62IAKgBp1GuHcKsWWczq82QUGEIHKukQLVGfPH60szFIs7o2ULNAs2hI74Ykf5yqRx7-ZiP7ih17uwpGn70blunqyGROIAeb-WAQbjArVL5At4St4X3wNc3cE9bHDcdNrbYLzgpxNuZiBX4vUCCXPynbm4By4skuDjxD91-tMivdp90eXPcrjLnj3cJIohK7mOdJejOWbZW1xdoXzAbbeUtDjWF9Q9G08Om8EcfTbZNI2486pcqWJo12NH9WosBIzTY-Wix9XXmZWh-3R=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa5a023c5-705e-4037-918a-edf40c616438_939x450.png" alt="" /></a><figcaption class="wp-element-caption">The Asian Financial Crisis saw major currencies quickly collapse. (Source:&nbsp;<a href="https://substack.com/redirect/48d241f2-f332-40a5-ad4c-7ebb39d30b2b?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">FRED</a>)</figcaption></figure>
I don't have many memories from the Dot-com Bubble bursting. Back then, I had little interest in or exposure to the stock market, and neither did the people around me. But I do remember watching 9/11 live on TV in my dorm with my roommates at Boston University. I remember not being able to get a hold of family members in New York and Kentucky because the phones were overloaded. I remember the extreme range of reactions from my friends: some fled Boston out of fear; some used it as an excuse to skip some classes; some explored joining the armed forces. Everyone was rattled. Everyone felt less safe.
And for my college friends and I, it soon became clear that we would all be entering a tighter job market with an elevated unemployment rate. Things weren't great.
<figure class="wp-block-image"><a href="https://substack.com/redirect/3012d5c1-016c-4c41-bd92-903bc05ed66d?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_Nb0sOgwPLHdgVjD8GPkACVilOFgV79U6eM4TgYfAGwnctzGbMR6ckGKGaMPPJmsb335K_PFhJz4WzItHVGkc-bciz_-F14_LohPnz1e2HpiOm2QhOBOd-J9EIHnekR9fLA1aNgN6uRaT1X3WbGbRx5DOGupi9ZDHNneKuAvXZGEmDVM3ReFQZBcUyY2f1H-Ay1mbnYPx4VYbn3W5AJiz5f6hjLhCVp-ffWkATcoPZI6z76v5VgSvSyrABDdTIpl0jEQnJHTd9V9EnXbPaFFJYucwOVhTrusQsdzlUGKQhL8qv42U2AvlkHz=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5a352b63-7540-4ce3-8c89-537c29545c92_939x465.png" alt="" /></a><figcaption class="wp-element-caption">The economy looked great when I entered college in 2000. It wasn't as great when I graduated in 2004. (Source:&nbsp;<a href="https://substack.com/redirect/489aeeec-4d13-46b3-9414-adcfd9c83d5a?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">FRED</a>)</figcaption></figure>
After graduating from college in 2004 and after months of searching, I randomly got a job as a contract paralegal where I got my first serious introduction to equity research. I quickly became hooked on learning about the what made the stock market move.&nbsp;<a href="https://substack.com/redirect/1b7f3cf6-9b8c-48b8-9e8c-657e8bb35809?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">In 2006</a>, I got a job at Forbes Newsletters researching and writing up stock picks. I also enrolled in the CFA program that year, which helped me develop a sophisticated understanding of things like mortgage backed securities, collateralized debt obligations, derivatives, and value-at-risk models.
This education super-charged my fear and my feeling of hopelessness as the world tipped into recession in 2007 and spiraled into Global Financial Crisis (GFC) in 2008. The more I understood, the more I felt like there was no way out of it. And many pundits seemed to agree. I remember respected financial market prognosticators going on TV and proclaiming that the government's bailouts of the big banks, the automakers, and the GSEs were proof that it was "the end of capitalism."
<figure class="wp-block-image"><a href="https://substack.com/redirect/066cd371-b8d8-4648-b40b-879d376f5e68?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NaHljZ6b-KoD6nT2WIv6xYdXPocFXWXu4HDJUY33P7BLHHUuuQ_fNcef2S4ee27E-mWgEAGeIAKHuTZutEw925FgEKQoJcsGaOFNx6uuhwUGHB80PHQmc79NaMeJi3P31c6CoqomzQ6O1nLY4H8AdfuHkSGpMw4-9ngz9pxbETBVMF83_jAQVwa8a-1W72rxOjozDed21eOENit9woECSpcIIkP4vX2JbKzhtQ4WKfAI00mG0nvj4CV2oSNoTAIDh-X74mBJC3__f0xwQ0KVRCGdfG7tHc03FeMW7gctrD4InpzQ2dt3rtJww=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0396d240-eb39-492f-925c-2a8f3825df94_1472x834.png" alt="" /></a><figcaption class="wp-element-caption">The S&amp;P 500 fell 57% from its Oct 2007 high of 1,565 to its March 2009 low of 666. (Source: Yahoo Finance)</figcaption></figure>
It wasn't the end of capitalism, though many were convinced the housing market would never come back as we entered a "<a href="https://substack.com/redirect/68d9f88d-7fd8-4862-8ff9-e7c83cc7921b?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">new normal</a>" of slow growth. Another popular phrase in the wake of the crisis was "<a href="https://substack.com/redirect/6cb20fca-d357-4cd6-b289-bee51a7d8229?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">secular stagnation</a>." Admittedly, I was sold on the idea that economic growth would forever be a long slog. You can't blame me. In 2010,&nbsp;<a href="https://substack.com/redirect/1b7f3cf6-9b8c-48b8-9e8c-657e8bb35809?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">I got laid off from my job</a>&nbsp;and I re-entered a job market flooded with unemployed people with backgrounds in finance.
But the post-GFC recovery helped me appreciate the resilience of the consumers and businesses propelling the economy forward. I got a great job in 2011, and over the next decade my income soared. Those years were riddled with numerous macro hiccups, but nothing could keep the economy and the stock market from accelerating again and blasting through record highs.
And then came the COVID-19 pandemic.
Those first 6-9 months were surreal. I remember feeling like I was living a sci-fi horror film. At many points I thought this new strange way of life would be permanent. Meanwhile, I was constantly worried that the whole economy would collapse on itself.
<figure class="wp-block-image"><a href="https://substack.com/redirect/0688f86e-f536-4b28-9774-f75e1a04a46d?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NbscFUtA6IwDvX5NqUG8Nn6t2luLEGjO3a3XB7MX6TCBprlzYQZAJM_uHvLxP7d4AJfLNYHRefSH_Er7I17FlRvRBHpeA6mhHqGCiHh3K-hpEduxkBNNBG19fTTnzyjVgV-XtvjCtlxH7qRsNMXrmtm-S6Zuoaoz4Fvk5k4rmmt_Bd_qMXqQHQFOT1DjsPAagFkDv1f1k3ZIbW_5cmkt03dS8AkuhXxL6DS6WThOZ9DJ-5nvGEcB9samE1oWNv7I3WHxqfxDhFqE79XUQJDokhNycPZtfhhztb7jEfa2lpps4m6iBhRokrN=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9c91b707-de5d-4221-ade3-af302a81b88a_939x465.png" alt="" /></a><figcaption class="wp-element-caption">COVID-19 caused the economy to nearly screech to a halt. (Source:&nbsp;<a href="https://substack.com/redirect/489aeeec-4d13-46b3-9414-adcfd9c83d5a?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">FRED</a>)</figcaption></figure>
The discovery of the vaccine certainly helped things turn around. Fast forward a few years, and most things in the economy are back to normal. Notably,&nbsp;<a href="https://substack.com/redirect/89de024a-89ed-401a-804f-8b1d28d3b361?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">cruise</a>&nbsp;and&nbsp;<a href="https://substack.com/redirect/fd044ff2-d85d-449e-898a-e92b554d80ba?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">air travel</a>&nbsp;have more than recovered as most people have gotten comfortable again with being in tight spaces with strangers —&nbsp;<a href="https://substack.com/redirect/ca970b27-04e4-4579-8604-6191fa0425a7?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">unless it's in an office for work</a>.
So despite the pain, the trauma, and even the loss of life, all these experiences eventually confirmed that we'll always bounce back.
<h2 class="wp-block-heading">People will always want things to be better &#x1f4c8;</h2>
The economy and the stock market have&nbsp;<a href="https://substack.com/redirect/0ac3db5d-094a-4e05-8ba2-568c104debf2?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">always had</a>&nbsp;an upward bias.
This makes sense&nbsp;<a href="https://substack.com/redirect/421fc3e1-659f-4eee-8449-f3ccc06c20d5?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">if you think about it</a>. There are way more people who want things to be better, not worse. And that demand incentivizes entrepreneurs and businesses to supply better goods and services. The winners in this process get bigger as revenue grows. Some even get big enough to get listed in the stock market. As revenue grows,&nbsp;<a href="https://substack.com/redirect/edda2a69-5be1-43a1-8786-99ad82579e8f?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">so do earnings</a>. And earnings drive stock prices.
I can't imagine anything changing these attitudes. Sure, there will be periods of when we feel angry and hopeless along the way. But we're never gonna wake up one day and decide we have everything we want or settle on the idea that what we've got can't be improved on.
And there will always be a sense of urgency. Even during difficult periods, people understand that life won't wait. You're getting older. You're kids are getting older. You're parents are getting older. If you have the resources,&nbsp;<a href="https://substack.com/redirect/cdba9ccf-e431-4691-add0-603ee3b2cd5f?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">you won't put your lives on hold</a>. This is bullish as it keeps the wheels on the economy spinning.
Sure, many things change after all the events I mentioned. But things are always changing. Importantly, the changes that stuck have never prevent the economy and the markets from setting new records.
<h2 class="wp-block-heading">Where we are today</h2>
If you've been following the news at all over the past two months, you've probably heard at least a few folks talking about how the Trump administration's approach to trade policy is damaging the U.S.'s standing in the world while also threatening to send the global economy into recession.
As the stock market tumbled, phrases like "<a href="https://substack.com/redirect/01ee3155-4eb4-40a5-8f63-26b5ac1895a4?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">sell America</a>" and "<a href="https://substack.com/redirect/c8b83f7d-203d-4e29-bae4-6879cb4e671c?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">end of American exceptionalism</a>" began to trend.&nbsp;<a href="https://substack.com/redirect/0e3bfd9a-aef4-447f-a3b3-5dc39ab36d0a?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Popular measures of investor sentiment</a>&nbsp;tanked.
<figure class="wp-block-image"><a href="https://substack.com/redirect/6a7ef8a2-1216-4073-a921-adb64c11fe1e?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NaY2UYtD_m_cCbiQrz03XzG6_fndw5nNrVMqzc_hzDYFLqXa7gZhAx_yg__5Pb3HA0i1-i8n4JGx7uNsuDwwfxT1PgQODmLHJYt7d-3jt8UJnq96h3Yid8wZhZJXPSpM4TtVBZ0qeu5sC5A7oPRLxt1AVcDZ1HVYXga1EDrhXxpy3k1lZCp_CcPtbiHF5pf2K_XDPm1hIFUSmbTLNgXM2rnYNIgyiDZ7Tm8nPJqAEs3_7z8RcN8jelSZDuFy9K2l7TkYMQ_EsrdJOdjvD9EQbq-jSzcvL02-f2H9vqhfQ1e2S0sOXJ-Mqt-Dw=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F412304bb-608f-4ee0-b9a4-76f38a1a9f03_1972x842.png" alt="" /></a><figcaption class="wp-element-caption">Barron's Big Money poll revealed historic levels of bearishness. (Source:&nbsp;<a href="https://substack.com/redirect/52ba27cc-a783-4128-a30d-b6f0e285e87c?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Barron's</a>)</figcaption></figure>
To be clear, I think the past two months created some damage, and we have yet to learn the extent of that damage. It's certainly possible that we're in a recession or headed for one. And it's certainly possible the stock market could take another leg lower.
But I'm nowhere near convinced that we're destined for a extended, multi-year period of turmoil and pain.
Our system is amazing at self-correcting. Whether it's through votes or something else, we always seem to find a way to get things back on track toward increasing prosperity and improving our standard of living.
And to repeat&nbsp;<a href="https://substack.com/redirect/29c413c7-c5cd-4845-b921-67ca23a9ede1?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">what I said last week</a>: There's basically three scenarios investors always have to consider: 1) Things improve from here, and the market goes up; 2) Things get worse before they get better, which means markets could fall before resuming a more firm rally; or 3) Things get worse and never get better.
If we're facing scenario 3, then we may have bigger problems than stocks not recovering. But scenario 3 has&nbsp;<a href="https://substack.com/redirect/84055449-e2e7-434a-9e0d-ab334afbeef6?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">never played out</a>.
Scenarios 1 and 2 favor long-term investors. Maybe things get worse before they get better. (Note:&nbsp;<a href="https://substack.com/redirect/f1a11344-054b-4ae9-b89d-52cc5dd2c420?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Timing market</a>&nbsp;bottoms is&nbsp;<a href="https://substack.com/redirect/e0630f35-18e4-4bdd-a1db-86faac336c59?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">nearly impossible</a>.) But staying long the stock market covers you in case the low of this cycle is behind us.
I'll leave you with Warren Buffett said earlier this month at&nbsp;<a href="https://substack.com/redirect/19bde3b3-6107-4aae-b826-8c47b51bd5d2?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Berkshire Hathaway's annual meeting</a>:
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">"We're always in the process of change. We'll always find all kinds of things to criticize in the country. …&nbsp;If you don't think the United States has changed since I was born in 1930… We've gone through all kinds of things. We've gone through great recessions. We've gone through world wars. We've gone through the development of the atomic bomb that we never dreamt of when I was born. So I would not get discouraged about the fact that it doesn't look like we've solved every problem that's come along."
</blockquote>
The 94-year-old investor has lived through everything, and he's made a fortune investing in the stock market along the way.
&#8211;

Equities

Government

Long Ideas

Macro Notification

Market Summary

Psychology

Opinion

Markets

Personal Finance

Remembering Moments When I Thought Things Took A Permanent Turn For The Worse

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.institutionalpropertyadvisors.com%2F&amp;esheet=54257117&amp;newsitemid=20250519504201&amp;lan=en-US&amp;anchor=Institutional+Property+Advisors+%28IPA%29&amp;index=1&amp;md5=e2951cec00b67290040dd5c556531169">Institutional Property Advisors (IPA)</a>, a division of <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.marcusmillichap.com%2F&amp;esheet=54257117&amp;newsitemid=20250519504201&amp;lan=en-US&amp;anchor=Marcus+%26amp%3B+Millichap+%28NYSE%3AMMI%29&amp;index=2&amp;md5=368a3f4e5f5cb1c099725e50b0f4cf77">Marcus &amp; Millichap (NYSE:</a><a href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) dedicated to serving the company's institutional clients, announced today the sale of Zaterra, a 392-unit multifamily property in Chandler, Arizona. The asset traded for $137.5 million, or $350,765 per unit.

Marcus & Millichap's Institutional Property Advisors Announces Sale Of Zaterra For $137.5M

Piper Sandler analyst Charles Neivert upgrades Methanex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) from Neutral to Overweight and raises the price target from $36 to $48.

MEOH

Piper Sandler Upgrades Methanex to Overweight, Raises Price Target to $48

U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest economy of its last <a href="https://www.benzinga.com/25/05/45492889/americas-credit-strength-just-got-cut-again-should-you-panic">top-tier credit rating. </a>
The S&amp;P 500 index hovered near Friday's close. A green end to the session would mark the sixth consecutive daily gain. The Nasdaq 100 also traded flat, while the Dow Jones Industrial Average outperformed, and small caps lagged. 
Bond markets initially reacted sharply, with 30-year Treasury yields spiking above 5% following the downgrade. Yet, buying interest emerged during the session, pulling yields back to 4.95%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) still was down 0.6% on the day. 
The U.S. dollar index (DXY) weakened 0.6% to 100.40, reflecting moderate selling pressure on the greenback. Sector performance was muted overall, except for energy, which fell 1.5%. Crude oil slipped 0.4%, while natural gas dropped 6% amid oversupply concerns. 
Gold rose 1% to $3,235 per ounce, supported by safe-haven flows. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rallied 2%, climbing above the $105,000 mark.
<h3 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,824.92</td>
<td>0.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,456.60</td>
<td>0.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,965.78</td>
<td>0.1 %</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,102.02</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 1:05 p.m. ET</figcaption></figure>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45497403/is-the-dollars-global-reserve-role-at-risk-after-moodys-downgrade">Is The Dollar&#8217;s Global Reserve Role At Risk After Moody&#8217;s Downgrade?</a></li>
</ul>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.1% up to $594.91.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.4% to $428.18.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;edged 0.1% higher to $522.01.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% to $208.80.</li>
<li>The&nbsp;Health Care&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) outperformed, up 0.7%; the&nbsp;Energy&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) jumped 8%, extending Friday's 6% surge, after several company executives bought shares <a href="https://www.benzinga.com/25/05/45493652/700m-asset-manager-exits-unitedhealth-stock-says-medicare-advantage-is-facing-a-perfect-storm">during the recent selloff</a>.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) rallied 21%, following a nearly 60% decline last week amid lower-than-expected earnings. </li>
<li>Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) surged 18% after the FDA approved its Nuvaxovid COVID-19 vaccine <a href="https://www.benzinga.com/government/regulations/25/05/45488265/novavax-wins-limited-fda-nod-for-covid-shot-cleared-only-for-seniors-high-risk-groups-amid-safety-scrutiny">for high-risk individuals</a>, including seniors over 65 and those aged 12–64 with underlying health conditions. Shares of Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) rose 6.4%.</li>
</ul>
Now Read: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45497403/is-the-dollars-global-reserve-role-at-risk-after-moodys-downgrade">Is The Dollar&#8217;s Global Reserve Role At Risk After Moody&#8217;s Downgrade?</a></li>
</ul>
Image: Shutterstock

Macro Economic Events

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

ETFs

SPDR Dow Jones Industrial Average ETF Trust

MRNA

NVAX

iShares Trust Barclays 20+ Year Treasury Bond Fund

Select Sector SPDR-Consumer Discretionary

Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday?

Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance, after the closing <a href="https://www.benzinga.com/quote/GLOB/earnings">bell on Thursday</a>.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
&#8220;Globant&#8217;s spirit of building and reinvention is stronger than ever. We are largely focused on AI-related opportunities, and assisting our clients in transforming their respective businesses and leveraging technology to drive growth and competitive advantages. Our comprehensive growth strategy unites our 100-squared client-centric vision with our industry-specialized AI Studios and subscription model. This strategy is powered by our AI Pods and the Globant Enterprise AI platform, which we believe positions Globant as the only player in the industry with such a comprehensive offering. With a robust pipeline and expected sequential growth for Q2, we are not just navigating the future; as builders, we are actively creating it, reaffirming our commitment to lead the next wave of technological transformation,&#8221; said Martín Migoya, Globant&#8217;s CEO and co-founder.
Globant shares gained 3.1% to trade at $104.67 on Monday.
These analysts made changes to their price targets on Globant following earnings announcement.
<ul class="wp-block-list">
<li>Goldman Sachs analyst James Schneider maintained Globant with a Neutral and lowered the price target from $225 to $120.</li>
<li>Mizuho analyst Dan Dolev maintained the stock with an Outperform rating and lowered the price target from $194 to $153.</li>
</ul>
Considering buying GLOB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="562" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-1024x562.png" alt="" class="wp-image-920178" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-1024x562.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Earnings

GLOB

Globant Analysts Slash Their Forecasts After Q1 Results

Northland Capital Markets analyst Jeff Grampp initiates coverage on Hallador Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNRG#NASDAQ">HNRG</a>) with a Outperform rating and announces Price Target of $23.

Initiation

HNRG

Northland Capital Markets Initiates Coverage On Hallador Energy with Outperform Rating, Announces Price Target of $23

Semler Scientific Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) shares are seeing increased attention to start the week after the company announced a new board appointment that&#8217;s causing a spike in chatter on <a href="https://www.benzinga.com/topic/social-media">various social platforms</a>.
What To Know: Semler Scientific, a technology company that has adopted a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) treasury strategy, on Monday announced that it <a href="https://www.benzinga.com/pressreleases/25/05/n45490896/semler-scientific-appoints-natalie-brunell-to-its-board-of-directors">appointed</a> crypto journalist and podcast host&nbsp;Natalie Brunell&nbsp;to its board of directors.
Brunell is an influential crypto educator and hosts a popular Bitcoin podcast called &#8220;Coin Stories.&#8221; The company on Monday said that its latest board addition reflects its continued commitment to its Bitcoin treasury strategy. 
&#8220;Natalie is a highly respected journalist and educator – and a leading advocate for&nbsp;Bitcoin, with a deep understanding of its role as a transformative asset. As the 4th&nbsp;largest U.S. public company on the&nbsp;Bitcoin&nbsp;Standard in terms of&nbsp;Bitcoin&nbsp;holdings, we believe we are a strategic asset. Her insights will be instrumental as we pursue our&nbsp;Bitcoin&nbsp;treasury strategy and aim to deliver long-term value to our stockholders,&#8221; said Eric Semler, chairman of Semler Scientific.
Semler is seeing increased attention on multiple social platforms, especially on X, where the company is being talked about in comparison to Strategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>). 
Strategy&#8217;s Michael Saylor <a href="https://x.com/saylor/status/1924440559634076050">congratulated</a> the Semler team on X in response to a post from the company&#8217;s chairman. He also <a href="https://x.com/saylor/status/1924444076192981375">responded</a> to a post from Brunell announcing the new appointment. 
In&nbsp;May 2024, Semler Scientific became the second publicly traded company in the U.S. to adopt a&nbsp;Bitcoin&nbsp;treasury strategy, which involves using proceeds from equity and debt financings, as well as cash flows from operations, to strategically accumulate&nbsp;Bitcoin.
Semler reported first-quarter financial results last week, reporting Bitcoin treasury highlights similar to Strategy. The company said it achieved a &#8220;BTC Yield&#8221; of 21.9% in the first quarter and reported a &#8220;BTC Gain&#8221; of 7.1 in the first quarter and 510.3 year-to-date. The company said it held a total of 3,192 Bitcoin as of March 31. 
SMLR Price Action: <a href="http://benzinga.com/quote/SMLR">Semler Scientific shares</a> were up 7.84% at $44.08 at the time of publication Monday, according to Benzinga Pro. The company&#8217;s stock is down approximately 18% year-to-date, but has risen 88% over a one-year period on the back of its Bitcoin treasury strategy announcement.
Photo: Yalcin Sonat/Shutterstock.

Movers

MSTR

SMLR

Bitcoin-Linked Semler Scientific Stock Is Trending On Monday: What's Going On?

Mizuho analyst Mara Goldstein maintains Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) with a Outperform and lowers the price target from $32 to $30.

KURA

Mizuho Maintains Outperform on Kura Oncology, Lowers Price Target to $30

Mizuho analyst Vijay Rakesh maintains Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Neutral and raises the price target from $32 to $40.

SMCI

Mizuho Maintains Neutral on Super Micro Computer, Raises Price Target to $40

TD Securities analyst Ryan Langston downgrades UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) from Buy to Hold and lowers the price target from $520 to $308.

Downgrades

TD Securities Downgrades UnitedHealth Group to Hold, Lowers Price Target to $308

Press Releases

Nuvation Bio to Present at the TD Cowen 45th Annual Health Care Conference

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners

Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

Comments

Nuvation Bio

空売り

Nuvation Bio (NYSE:NUVB) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル